300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Retail
Oil and Gas
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
LATAM
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Rwanda
Portugal
El Salvador
Sierra Leone
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Bangladesh
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Azerbaijan
Austria
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bolivia
Belize
Bahamas
Algeria
Italy
Hungary
Belarus
Finland
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Mongolia
Lebanon
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Tsing-Yuan Capital, VC Fund

Tsing-Yuan Capital

VC Fund

Shenzhen, China

Tsing-Yuan Capital is a Chinese venture capital firm specialized in early, middle, and mature stage investments.

Total investments:
59
Last investment:
Lead investor:
31%

Last updated:

Industries Tsing-Yuan Capital invests in

ManufacturingMedicalHealth CareE-CommerceInformation Technology

Stages Tsing-Yuan Capital invests in

Series AAngelSeedSeries BSeries C

Countries Tsing-Yuan Capital invests in

ChinaUnited States

Round sizes

Seed $485k–$15MAngel $425k–$472kSeries A $1.4M–$16M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$485k–$15M
Angel
$425k–$472k
Series A
$1.4M–$16M

Investment Focus

Industry

  • Manufacturing 12 (20%)
  • Medical 6 (10%)
  • Health Care 6 (10%)
  • E-Commerce 5 (8%)
  • Information Technology 5 (8%)
See all 88 industries →

Stage

  • Series A 17 (29%)
  • Angel 12 (20%)
  • Seed 10 (17%)
  • Series B 7 (12%)
  • Series C 5 (8%)
See all 9 stages →

Country

  • China 43 (73%)
  • United States 2 (3%)

Team

NameTitleInvestmentsLinksEmail
Jianyun Liu
Jianyun Liu President, Executive Partner
President, Executive Partner Total investments: 0 Find email
Pan Haifeng Partner
Partner Total investments: 1 Find email

Investments

CompanyDescriptionRoundLinks
Kangwei Vision Technology is a high-tech enterprise specializing in high-end semiconductor optical inspection equipment. $14.9M / Seed / Sep 15, 2026
Leo Summit Leo Summit
Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing. Venture - Series Unknown / Jul 03, 2026
Lilai Intelligent Manufacturing is a steel and aluminum provider that combines trading, shearing, processing, transportation, distribution, and information services. $28.6M / Series E / Jan 04, 2026
Bozhong Teda is a manufacturer specializing in ultra-precision machining and testing equipment. Series A / Nov 24, 2025
Chaoqun Testing Technology is an X-ray equipment manufacturer that focuses on the design and manufacturing of industrial and medical X-ray tubes, sources, and systems. $70.2M / Venture - Series Unknown / Oct 24, 2025
Suzhou Saidel Intelligent Technology Co., Ltd. is committed to the research and development and application of cutting-edge technologies in the field of electromagnetics, and strives to transform the most cutting-edge theories into industrial products, providing customers with the most advantageous products and services, and driving the future withinnovation. Series A / Jul 18, 2025
Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment. Seed / Apr 22, 2025
Maimu Intelligence's solution is built on industrial machine vision and artificial intelligence deep learning technologies. It can automatically detect and classify defects, achieve real-time data recording and traceability, and assist in process improvement to reduce costs and increase efficiency by creating a corresponding defect data samplelibrary and a self-learning defect automatic detection neural network model. $1.4M / Seed / Sep 18, 2024
Tianfu Gaofen is primarily focused on the development and operation of the "Gaofen Earth-1" high-resolution optical remote sensing satellite constellation as a remote sensing picture data Provider. Series A / Sep 04, 2024
Baynoe Chem is a novel material research and development platform. Baynoe Chem is committed to the R&D, production, and sales of high-purity OLED new materials and intermediates, and fine chemical products, it has developed and produced more than 1,000 OLED series products, including dibenzofurans, dibenzothiophenes, carbazoles, Azines,halogenated benzenes, naphthalene rings, phenanthrenes, pyrenes, boric acids, polybiphenyls, etc., and has provided stable and reliable technical support and product supply to many domestic and foreign OLED finished materials. Many clients have formed long-term cooperative ties. Venture - Series Unknown / May 20, 2024
See all 59 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Retail
Oil and Gas
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
LATAM
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Rwanda
Portugal
El Salvador
Sierra Leone
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Bangladesh
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Azerbaijan
Austria
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bolivia
Belize
Bahamas
Algeria
Italy
Hungary
Belarus
Finland
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Mongolia
Lebanon
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Tsing-Yuan Capital invest in?

Tsing-Yuan Capital invests primarily in Manufacturing, Medical and Health Care startups, most often at Series A and Angel stage. Most of the 59 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Tsing-Yuan Capital's check size?

Tsing-Yuan Capital typically joins rounds of $485k–$15M at Seed, $425k–$472k at Angel and $1.4M–$16M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tsing-Yuan Capital participates in.

How do I contact Tsing-Yuan Capital?

Public channels for Tsing-Yuan Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Tsing-Yuan Capital?

The team at Tsing-Yuan Capital includes Jianyun Liu (President, Executive Partner) and Pan Haifeng (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Tsing-Yuan Capital Tsing-Yuan Capital Find emails